US6410516B1
(en)
|
1986-01-09 |
2002-06-25 |
President & Fellows Of Harvard College |
Nuclear factors associated with transcriptional regulation
|
IL99731A0
(en)
|
1990-10-18 |
1992-08-18 |
Merck & Co Inc |
Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
US6273913B1
(en)
|
1997-04-18 |
2001-08-14 |
Cordis Corporation |
Modified stent useful for delivery of drugs along stent strut
|
AU1853600A
(en)
|
1999-01-06 |
2000-07-24 |
Choong-Chin Liew |
Method for the detection of gene transcripts in blood and uses thereof
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
US20030105124A1
(en)
|
2000-04-27 |
2003-06-05 |
Susan Beth Sobolov-Jaynes |
Substituted benzolactam compounds
|
JP2005532368A
(ja)
|
2002-06-12 |
2005-10-27 |
アボット・ラボラトリーズ |
メラニン濃縮ホルモン受容体の拮抗薬
|
US20040067234A1
(en)
|
2002-07-11 |
2004-04-08 |
Paz Einat |
Isocitrate dehydrogenase and uses thereof
|
US7699767B2
(en)
|
2002-07-31 |
2010-04-20 |
Arryx, Inc. |
Multiple laminar flow-based particle and cellular separation with laser steering
|
BRPI0406667A
(pt)
|
2003-01-10 |
2005-12-20 |
Threshold Pharmaceuticals Inc |
Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg
|
RU2284325C2
(ru)
|
2003-12-17 |
2006-09-27 |
Общество С Ограниченной Ответственностью "Асинэкс Медхим" |
Производные фенил-3-аминометил-хинолона-2 в качестве ингибиторов no-синтетазы, способ их получения, биологически активные соединения и фармацевтическая композиция на их основе
|
US8062033B2
(en)
|
2004-06-08 |
2011-11-22 |
Gold Standard Instruments, LLC |
Dental and medical instruments comprising titanium
|
WO2006054912A1
(fr)
|
2004-11-18 |
2006-05-26 |
Obchestvo S Ogranichennoy Otvetstvennost'u 'asineks Medhim' |
Derives d'aryl(hetaryl)-3-aminomethylchinolone-2 utilises en tant qu'inhibiteurs de no-synthetase et de cyclo-oxygenase-2, procedes de leur fabrication et compositions pharmaceutiques sur leur base
|
EP1899486A4
(en)
|
2005-06-08 |
2009-07-22 |
Millennium Pharm Inc |
METHOD FOR IDENTIFYING, ASSESSING AND TREATING PATIENTS IN CANCER THERAPY
|
TW200803855A
(en)
|
2006-02-24 |
2008-01-16 |
Kalypsys Inc |
Quinolones useful as inducible nitric oxide synthase inhibitors
|
AU2007275816A1
(en)
|
2006-07-17 |
2008-01-24 |
Merck Sharp & Dohme Corp. |
1-hydroxy naphthyridine compounds as anti-HIV agents
|
JP2010043004A
(ja)
|
2006-12-06 |
2010-02-25 |
Dainippon Sumitomo Pharma Co Ltd |
新規2環性複素環化合物
|
CN101679321B
(zh)
|
2007-04-30 |
2012-10-03 |
普罗米蒂克生物科学公司 |
三嗪衍生物、含所述衍生物的组合物以及所述衍生物在制备用于治疗癌症和自身免疫性疾病药物中的应用
|
JP5421374B2
(ja)
|
2008-09-03 |
2014-02-19 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
悪性神経膠腫におけるイソクエン酸デヒドロゲナーゼ遺伝子および他の遺伝子の遺伝子変化
|
CN102985557B
(zh)
|
2009-03-13 |
2018-06-15 |
安吉奥斯医药品有限公司 |
用于细胞增殖相关病症的方法和组合物
|
EP2253716A1
(en)
|
2009-05-15 |
2010-11-24 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Diagnostic methods for the prognosis of a brain tumor
|
JP2012529511A
(ja)
|
2009-06-08 |
2012-11-22 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
EP2525790B1
(en)
|
2009-10-21 |
2020-05-27 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
ES2594402T3
(es)
|
2009-10-21 |
2016-12-20 |
Agios Pharmaceuticals, Inc. |
Métodos y composiciones para trastornos relacionados con la proliferación celular
|
JP5967827B2
(ja)
|
2009-12-09 |
2016-08-10 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
Idh変異体をもつことを特徴とする癌治療用の治療的活性化合物
|
US9335332B2
(en)
|
2010-04-01 |
2016-05-10 |
Council Of Scientific And Industrial Research |
Nicotinamide phosphoribosyltransferase (NMPRTase) inhibitor for glioma therapy
|
US9073941B2
(en)
|
2010-06-28 |
2015-07-07 |
Academia Sinica |
Compounds and methods for treating tuberculosis infection
|
RU2596738C9
(ru)
|
2010-09-23 |
2016-11-10 |
Инвиста Текнолоджиз С.А Р.Л. |
Огнестойкие волокна, пряжа и ткани из них
|
US9695400B2
(en)
|
2010-10-22 |
2017-07-04 |
Duke University |
Homozygous and heterozygous IDH1 gene-defective human astrocytoma cell lines
|
CN102558049B
(zh)
|
2010-12-17 |
2015-02-04 |
中国科学院上海药物研究所 |
一类双香豆素类化合物及其制备方法和用途
|
US8469749B2
(en)
|
2010-12-17 |
2013-06-25 |
Research In Motion Limited |
Two-part jack socket for a portable electronic device
|
US20120184562A1
(en)
|
2011-01-19 |
2012-07-19 |
Kin-Chun Luk |
1,6- and 1,8-naphthyridines
|
US20120184548A1
(en)
|
2011-01-19 |
2012-07-19 |
Romyr Dominique |
Carboxylic acid aryl amides
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
WO2012173682A2
(en)
|
2011-03-29 |
2012-12-20 |
The Broad Institute, Inc. |
Compounds and methods for the treatment of isocitrate dehydrognase related diseases
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN103814020B
(zh)
|
2011-06-17 |
2017-07-14 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
KR20140069235A
(ko)
|
2011-09-27 |
2014-06-09 |
노파르티스 아게 |
돌연변이체 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온
|
WO2013096820A1
(en)
|
2011-12-21 |
2013-06-27 |
The Regents Of The University Of Colorado |
Anti-cancer compounds targeting ral gtpases and methods of using the same
|
NZ627096A
(en)
|
2012-01-06 |
2017-02-24 |
Agios Pharmaceuticals Inc |
Triazinyl compounds and their methods of use
|
JP6228130B2
(ja)
|
2012-01-19 |
2017-11-08 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
治療活性化合物およびそれらの使用方法
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
EP2634259A1
(en)
|
2012-03-01 |
2013-09-04 |
Deutsches Krebsforschungszentrum |
Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)
|
US8882892B2
(en)
|
2013-02-04 |
2014-11-11 |
Nordson Corporation |
Powder coating system having powder recovery cyclone with hinged lower section
|
WO2014141153A1
(en)
|
2013-03-14 |
2014-09-18 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
|
WO2014147586A1
(en)
|
2013-03-22 |
2014-09-25 |
Novartis Ag |
1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh
|
WO2014184272A2
(en)
|
2013-05-14 |
2014-11-20 |
Medizinische Hochschule Hannover |
Means and methods for treating cancer
|
US10478445B2
(en)
|
2013-07-03 |
2019-11-19 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
EA031655B1
(ru)
|
2014-02-11 |
2019-02-28 |
Байер Фарма Акциенгезельшафт |
Бензимидазол-2-амины в качестве ингибиторов midhi
|
ES2768694T3
(es)
|
2014-09-19 |
2020-06-23 |
Forma Therapeutics Inc |
Composiciones de quinolinona pirimidinas como inhibidores de isocitrato dehidrogenasa mutante
|
JP6751081B2
(ja)
|
2014-09-19 |
2020-09-02 |
フォーマ セラピューティクス,インコーポレイテッド |
変異イソクエン酸デヒドロゲナーゼ阻害剤としてのピリジニルキノリノン誘導体
|
WO2016044782A1
(en)
|
2014-09-19 |
2016-03-24 |
Forma Therapeutics, Inc. |
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
|
CN117695280A
(zh)
|
2014-09-19 |
2024-03-15 |
福马治疗股份有限公司 |
作为突变型异柠檬酸脱氢酶抑制剂的吡啶-2(1h)-酮喹啉酮衍生物
|
EP3237385B1
(en)
|
2014-12-22 |
2021-11-24 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Mutant idh1 inhibitors useful for treating cancer
|
GB2533925A
(en)
|
2014-12-31 |
2016-07-13 |
Univ Bath |
Antimicrobial compounds, compositions and methods
|
WO2016171755A1
(en)
|
2015-04-21 |
2016-10-27 |
Forma Therapeutics, Inc. |
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
|
US9624216B2
(en)
|
2015-04-21 |
2017-04-18 |
Forma Therapeutics, Inc. |
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
|
ES2764523T3
(es)
|
2015-07-27 |
2020-06-03 |
Lilly Co Eli |
Compuestos de 7-feniletilamino-4H-pirimido[4,5-D][1,3]oxazin-2-ona y su uso como inhibidores de IDH1 mutantes
|
CA3007218A1
(en)
|
2015-12-04 |
2017-06-08 |
Agios Pharmaceuticals, Inc. |
Methods of treatment of malignancies
|
WO2017146794A1
(en)
|
2016-02-26 |
2017-08-31 |
Celgene Corporation |
Idh2 inhibitors for the treatment of haematological maligancies and solid tumours
|
JP6682043B2
(ja)
|
2016-06-06 |
2020-04-15 |
イーライ リリー アンド カンパニー |
変異体idh1阻害剤
|
US10836759B2
(en)
|
2016-06-22 |
2020-11-17 |
The University Of North Carolina At Chapel Hill |
Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer
|
CN115109075A
(zh)
|
2016-12-16 |
2022-09-27 |
伊莱利利公司 |
突变体idh1和idh2抑制剂
|
US10645695B2
(en)
|
2017-08-08 |
2020-05-05 |
Aviat U.S., Inc. |
Traffic management technique for variable bandwidth networks using RSVP
|
WO2019032744A1
(en)
|
2017-08-11 |
2019-02-14 |
Panacea Pharmaceticals Inc. |
HAAH AND MMP-9 AS COMPLEMENTARY CANCER BIOMARKERS AND METASTASE PREDICTORS WHEN COMBINING THEM
|
HUE061331T2
(hu)
|
2018-05-16 |
2023-06-28 |
Forma Therapeutics Inc |
Mutáns IDH-1 gátlása
|
US11311527B2
(en)
|
2018-05-16 |
2022-04-26 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
|
US10532047B2
(en)
|
2018-05-16 |
2020-01-14 |
Forma Therapeutics, Inc. |
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
|
US11013734B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
|
WO2020232381A1
(en)
|
2019-05-16 |
2020-11-19 |
Forma Therapeutics, Inc. |
INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
|
US11013733B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
|